AAAAAA

   
Results: 1-25 | 26-50 | 51-52
Results: 1-25/52
Thalidomide for previously untreated indolent or smoldering multiple myeloma
Authors: Rajkumar, SV Dispenzieri, A Fonseca, R Lacy, MQ Geyer, S Lust, JA Kyle, RA Greipp, PR Gertz, MA Witzig, TE
Citation: Sv. Rajkumar et al., Thalidomide for previously untreated indolent or smoldering multiple myeloma, LEUKEMIA, 15(8), 2001, pp. 1274-1276
Caring (really) for patients who use alternative therapies for cancer
Authors: Gertz, MA Bauer, BA
Citation: Ma. Gertz et Ba. Bauer, Caring (really) for patients who use alternative therapies for cancer, J CL ONCOL, 19(23), 2001, pp. 4346-4349
Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival
Authors: Dispenzieri, A Lacy, MQ Kyle, RA Therneau, TM Larson, DR Rajkumar, SV Fonseca, R Greipp, PR Witzig, TE Lust, JA Gertz, MA
Citation: A. Dispenzieri et al., Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival, J CL ONCOL, 19(14), 2001, pp. 3350-3356
Methods for estimation of bone marrow plasma cell involvement in myeloma: Predictive value for response and survival in patients undergoing autologous stem cell transplantation
Authors: Rajkumar, SV Fonseca, R Dispenzieri, A Lacy, MQ Lust, JA Witzig, TE Therneau, TM Kyle, RA Greipp, PR Gertz, MA
Citation: Sv. Rajkumar et al., Methods for estimation of bone marrow plasma cell involvement in myeloma: Predictive value for response and survival in patients undergoing autologous stem cell transplantation, AM J HEMAT, 68(4), 2001, pp. 269-275
High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis
Authors: Kumar, S Dispenzieri, A Lacy, MQ Litzow, MR Gertz, MA
Citation: S. Kumar et al., High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis, BONE MAR TR, 28(4), 2001, pp. 381-385
Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation
Authors: Hogan, WJ Lacy, MQ Wiseman, GA Fealey, RD Dispenzieri, A Gertz, MA
Citation: Wj. Hogan et al., Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation, BONE MAR TR, 28(3), 2001, pp. 305-309
Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia
Authors: Kumar, S Chen, MG Gastineau, DA Gertz, MA Inwards, DJ Lacy, MQ Tefferi, A Litzow, MR
Citation: S. Kumar et al., Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia, BONE MAR TR, 28(10), 2001, pp. 951-956
Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation
Authors: Capizzi, SA Kumar, S Huneke, NE Gertz, MA Inwards, DJ Litzow, MR Lacy, MQ Gastineau, DA Prakash, UBS Tefferi, A
Citation: Sa. Capizzi et al., Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation, BONE MAR TR, 27(12), 2001, pp. 1299-1303
Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease
Authors: Kumar, S Chen, MG Gastineau, DA Gertz, MA Inwards, DJ Lacy, MQ Tefferi, A Harmsen, WS Litzow, MR
Citation: S. Kumar et al., Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease, BONE MAR TR, 27(11), 2001, pp. 1133-1140
Retrospective cohort study of 148 patients with polyclonal gammopathy
Authors: Dispenzieri, A Gertz, MA Therneau, TM Kyle, RA
Citation: A. Dispenzieri et al., Retrospective cohort study of 148 patients with polyclonal gammopathy, MAYO CLIN P, 76(5), 2001, pp. 476-487
Pulmonary marginal zone lymphoma of MALT type as a cause of localised pulmonary amyloidosis
Authors: Lim, JK Lacy, MQ Kurtin, PJ Kyle, RA Gertz, MA
Citation: Jk. Lim et al., Pulmonary marginal zone lymphoma of MALT type as a cause of localised pulmonary amyloidosis, J CLIN PATH, 54(8), 2001, pp. 642-646
Pulmonary hypertension in patients with amyloidosis
Authors: Dingli, D Utz, JP Gertz, MA
Citation: D. Dingli et al., Pulmonary hypertension in patients with amyloidosis, CHEST, 120(5), 2001, pp. 1735-1738
Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients
Authors: Casassus, P Gibson, J Joshua, DE Matthews, J Diaz, JC Gertz, MA Kyle, R Leong, T Oken, MM Fritz, E Ludwig, H Corrado, C Lastiri, F Peest, D Grosbois, B Vela-Ojeda, J Avvisati, G Mandelli, F Petrucci, MT Capnist, G Child, JA Drayson, MT Dunn, J MacLennan, I Mellstedt, H Osterborg, A Rodjer, S Turesson, I Westin, J Bergsagel, D Browman, GP Shustik, C Zee, B Hjorth, M Holmberg, E Rodjer, S Turesson, I Westin, J Alison, R Clarke, M Elphinstone, P Evans, V Gray, R Hicks, C James, S MacKinnon, L Peto, R Richards, S Wheatley, K Blade, J Fontanillas, M San Miguel, J Aitchison, R Newland, AC Cunningham, D Malpas, J Powles, RL Montuoro, A Jacobson, J Salmon, S
Citation: P. Casassus et al., Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients, BR J HAEM, 113(4), 2001, pp. 1020-1034
Translocations involving the immunoglobulin heavy-chain locus are possibleearly genetic events in patients with primary systemic amyloidosis
Authors: Hayman, SR Bailey, RJ Jalal, SM Ahmann, GJ Dispenzieri, A Gertz, MA Greipp, PR Kyle, RA Lacy, MQ Rajkumar, SV Witzig, TE Lust, JA Fonseca, R
Citation: Sr. Hayman et al., Translocations involving the immunoglobulin heavy-chain locus are possibleearly genetic events in patients with primary systemic amyloidosis, BLOOD, 98(7), 2001, pp. 2266-2268
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma
Authors: Porrata, LF Gertz, MA Inwards, DJ Litzow, MR Lacy, MQ Tefferi, A Gastineau, DA Dispenzieri, A Ansell, SM Micallef, INM Geyer, SM Markovic, SN
Citation: Lf. Porrata et al., Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma, BLOOD, 98(3), 2001, pp. 579-585
Prognostic factors and response to fludarabine therapy in patients with Waldenstrom macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003)
Authors: Dhodapkar, MV Jacobson, JL Gertz, MA Rivkin, SE Roodman, GD Tuscano, JM Shurafa, M Kyle, RA Crowley, JJ Barlogie, B
Citation: Mv. Dhodapkar et al., Prognostic factors and response to fludarabine therapy in patients with Waldenstrom macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003), BLOOD, 98(1), 2001, pp. 41-48
A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death
Authors: Steensma, DP Gertz, MA Greipp, PR Kyle, RA Lacy, MQ Lust, JA Offord, JR Plevak, MF Therneau, TM Witzig, TE
Citation: Dp. Steensma et al., A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death, BLOOD, 97(8), 2001, pp. 2522-2523
Clonal evolution in Waldenstrom macroglobulinemia highlights functional role of B-cell receptor
Authors: Ciric, B VanKeulen, V Rodriguez, M Kyle, RA Gertz, MA Pease, LR
Citation: B. Ciric et al., Clonal evolution in Waldenstrom macroglobulinemia highlights functional role of B-cell receptor, BLOOD, 97(1), 2001, pp. 321-323
Primary systemic amyloidosis: A cause of malabsorption syndrome
Authors: Hayman, SR Lacy, MQ Kyle, RA Gertz, MA
Citation: Sr. Hayman et al., Primary systemic amyloidosis: A cause of malabsorption syndrome, AM J MED, 111(7), 2001, pp. 535-540
Fatal pulmonary toxicity related to the administration of granulocyte colony-stimulating factor in amyloidosis: A report and review of growth factor-induced pulmonary toxicity
Authors: Gertz, MA Lacy, MQ Bjornsson, J Litzow, MR
Citation: Ma. Gertz et al., Fatal pulmonary toxicity related to the administration of granulocyte colony-stimulating factor in amyloidosis: A report and review of growth factor-induced pulmonary toxicity, J HEMATH ST, 9(5), 2000, pp. 635-643
Prognostic value of bone marrow angiogenesis in multiple myeloma
Authors: Rajkumar, SV Leong, T Roche, PC Fonseca, R Dispenzieri, A Lacy, MQ Lust, JA Witzig, TE Kyle, RA Gertz, MA Greipp, PR
Citation: Sv. Rajkumar et al., Prognostic value of bone marrow angiogenesis in multiple myeloma, CLIN CANC R, 6(8), 2000, pp. 3111-3116
FISH demonstrates treatment-related chromosome damage in myeloid but not plasma cells in primary systemic amyloidosis
Authors: Fonseca, R Rajkumar, SV Ahmann, GJ Jalal, SM Hoyer, JD Gertz, MA Kyle, RA Greipp, PR Dewald, GW
Citation: R. Fonseca et al., FISH demonstrates treatment-related chromosome damage in myeloid but not plasma cells in primary systemic amyloidosis, LEUK LYMPH, 39(3-4), 2000, pp. 391
Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL)
Authors: Gertz, MA Lacy, MQ Gastineau, DA Inwards, DJ Chen, MG Tefferi, A Kyle, RA Litzow, MR
Citation: Ma. Gertz et al., Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL), BONE MAR TR, 26(9), 2000, pp. 963-969
Effect of complete response on outcome following autologous stem cell transplantation for myeloma
Authors: Rajkumar, SV Fonseca, R Dispenzieri, A Lacy, MQ Witzig, TE Lust, JA Larson, D Therneau, TM Kyle, RA Litzow, MR Greipp, PR Gertz, MA
Citation: Sv. Rajkumar et al., Effect of complete response on outcome following autologous stem cell transplantation for myeloma, BONE MAR TR, 26(9), 2000, pp. 979-983
Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma
Authors: Gertz, MA Lacy, MQ Inwards, DJ Gastineau, DA Tefferi, A Chen, MG Witzig, TE Greipp, PR Litzow, MR
Citation: Ma. Gertz et al., Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma, BONE MAR TR, 26(1), 2000, pp. 45-50
Risultati: 1-25 | 26-50 | 51-52